The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone followed adjuvant therapy in biliary tract cancer: Final results from the phase III AIO/CALGP/ACO-GAIN-Trial.
 
Thorsten Goetze
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Foundation Medicine; Incyte; Lilly; MSD Oncology; Novartis; Roche; SERVIER
Speakers' Bureau - Lilly; MSD Oncology
Research Funding - AstraZeneca (Inst); Deutsche Forschungsgemeinschaft; Deutsche Krebshilfe (Inst); Gemeinsamer Bundesausschuss; Incyte (Inst); Lilly (Inst)
 
Arndt Vogel
Honoraria - Amgen; AstraZeneca/MedImmune; BeiGene; Boehringer Pharma GmbH; Boston Scientific; Bristol-Myers Squibb; Daichi-Sankyo; Eisai; GlaxoSmithKline; Incyte; Ipsen; Janssen; Lilly; MSD; Pierre Fabre; Roche; SERVIER; Sirtex Medical; Sirtex Medical; Taiho Oncology; TERUMO
Consulting or Advisory Role - Amgen; AstraZeneca; Baxalta; Boehringer Pharma GmbH; BTG; Daichi-Sankyo; EISAI; Incyte; IPSEN; Lilly; Novartis; Pierre Fabre; Roche; Sirtex Medical; Taiho Oncology; Taiho Oncology; Terumo
Research Funding - Novartis
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Lilly; MSD; Roche
 
Johann Pratschke
Honoraria - Baxter; Chiesi; MERCK; North-East German Society for Gynecological Oncology (NOGGO)
Consulting or Advisory Role - Baxter; Chiesi
Travel, Accommodations, Expenses - Baxter; Chiesi; Intuitive Surgical; Medtronic; MERCK
 
Matthias Behrend
No Relationships to Disclose
 
Daniel Reim
No Relationships to Disclose
 
Andreas Schnitzbauer
No Relationships to Disclose
 
Annalen Bleckmann Prof. Dr.
Honoraria - AstraZeneca; Bayer/Vital; BMS GmbH & Co. KGaA; Boehringer Ingelheim; Daiichi Sankyo; Janssen-Cilag; Lilly; MSD Sharp & Dohme GmbH; Novartis; Onkowissen.de GmbH; Pfizer; Roche; Sanofi GmbH; Takeda GmbH
Consulting or Advisory Role - AstraZeneca; Bayer/Vital; BMS GmbH & Co. KGaA; Boehringer Ingelheim; Daiichi Sankyo; Janssen-Cilag; Lilly; MSD Sharp & Dohme GmbH; Novartis; Onkowissen.de GmbH; Pfizer; Roche; Sanofi GmbH; Takeda GmbH
Research Funding - AstraZeneca (Inst); Daiichi Sankyo (Inst); Lilly (Inst); Sanofi GmbH (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer/Vital; BMS GmbH & Co. KGaA; Boehringer Ingelheim; Daiichi Sankyo; Janssen-Cilag; Lilly; MSD Sharp & Dohme GmbH; Novartis; Onkowissen.de GmbH; Onkowissen.de GmbH; Pfizer; Roche; Sanofi GmbH; Takeda GmbH
 
Silvan Becker
Consulting or Advisory Role - Amgen; AstraZeneca Canada; BeiGene; BMS GmbH & Co. KG
Travel, Accommodations, Expenses - Ipsen; Sanofi
 
Nuh Rahbari
Honoraria - Medtronic; Olympus
Consulting or Advisory Role - Medtronic; Olympus
 
Stefan Brunner
No Relationships to Disclose
 
Steffen Manekeller
No Relationships to Disclose
 
Kim Luley
Honoraria - Merck Serono; Pierre Fabre
Consulting or Advisory Role - SERVIER
Travel, Accommodations, Expenses - Merck Serono; Pierre Fabre
 
Sven Arke Lang
No Relationships to Disclose
 
Kerstin Gutsche
No Relationships to Disclose
 
Timorshah Habibzada
No Relationships to Disclose
 
Jorge Klagges
No Relationships to Disclose
 
Marina Schaaf
No Relationships to Disclose
 
Claudia Pauligk
No Relationships to Disclose
 
Ulli Bankstahl
No Relationships to Disclose
 
Salah-Eddin Al-Batran
Stock and Other Ownership Interests - Frankfurter Institut für Klinische Krebsforschung IKF GmbH
Consulting or Advisory Role - Bristol-Myers Squibb; Eli Lilly Germany; Merck Sharp & Dohme
Speakers' Bureau - MCI Group
Research Funding - AstraZeneca; Bristol-Myers Squibb; Celgene; Eurozyto; Federal Ministry of Education and Research; German Cancer Aid; German Research Foundation; Immutep; Ipsen; Lilly; MSD Sharp & Dohme; Roche; Sanofi; Vifor Pharma